| Literature DB >> 27340089 |
Shih-Hsin Kan1, Steven Q Le1, Quang D Bui1, Braeden Benedict1, Jesse Cushman2, Mark S Sands3, Patricia I Dickson4.
Abstract
Sanfilippo B syndrome is a progressive neurological disorder caused by inability to catabolize heparan sulfate glycosaminoglycans. We studied neurobehavior in male Sanfilippo B mice and heterozygous littermate controls from 16 to 20 weeks of age. Affected mice showed reduced anxiety, with a decrease in the number of stretch-attend postures during the elevated plus maze (p=0.001) and an increased tendency to linger in the center of an open field (p=0.032). Water maze testing showed impaired spatial learning, with reduced preference for the target quadrant (p=0.01). In radial arm maze testing, affected mice failed to achieve above-chance performance in a win-shift working memory task (t-test relative to 50% chance: p=0.289), relative to controls (p=0.037). We found a 12.4% reduction in mean acetylcholinesterase activity (p<0.001) and no difference in choline acetyltransferase activity or acetylcholine in whole brain of affected male animals compared to controls. Cholinergic pathways are affected in adult-onset dementias, including Alzheimer disease. Our results suggest that male Sanfilippo B mice display neurobehavioral deficits at a relatively early age, and that as in adult dementias, they may display deficits in cholinergic pathways.Entities:
Keywords: Acetylcholinesterase; Glycosaminoglycan; Inborn error of metabolism; Lysosomal; Mucopolysaccharidosis; Neurodegeneration
Mesh:
Substances:
Year: 2016 PMID: 27340089 PMCID: PMC4970944 DOI: 10.1016/j.bbr.2016.06.023
Source DB: PubMed Journal: Behav Brain Res ISSN: 0166-4328 Impact factor: 3.332